240. Phenylketonuria Clinical trials / Disease details


Clinical trials : 143 Drugs : 90 - (DrugBank : 10) / Drug target gene : 1 - Drug target pathways : 5

  
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05579548
(ClinicalTrials.gov)
October 4, 202211/10/2022A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynziq® (Pegvaliase) During Pregnancy and BreastfeedingA Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynziq® (Pegvaliase) During Pregnancy and BreastfeedingPhenylketonuria, MaternalDrug: PegvaliaseBioMarin PharmaceuticalSyneos HealthRecruitingN/AN/AFemale50United States
2NCT05356377
(ClinicalTrials.gov)
May 25, 202227/4/2022Preliminary Study of Brain Effects of Palynziq-Related Changes in Phenylalanine in Individuals With PKUA Preliminary Study of the Neurological and Neuropsychological Effects of Palynziq-Related Changes in Phenylalanine in Individuals With Phenylketonuria (PKU)PhenylketonuriasDrug: Pegvaliase-PqpzUniversity of Missouri-ColumbiaBioMarin PharmaceuticalEnrolling by invitation18 Years55 YearsAll13United States
3NCT04404530
(ClinicalTrials.gov)
October 8, 201921/5/2020Nutritional Impacts of Palynziq on Patients With Phenylketonuria (PKU)Palynziq and PKU: Treatment Impacts on Diet Quality, Neurological Health, Nutritional Status, and the MetabolomePhenylketonuriasDrug: PalynziqEmory UniversityBioMarin PharmaceuticalRecruiting16 YearsN/AAll45United States